4-[3-[ethyl[3-((R*)-(propylsulfinyl)propyl]amino]-2(R)-hydroxypropoxy]-benzonitrile,
4-[3-[ethyl[3-((S*)-(propylsulfinyl)propyl]amino]-2(R)-hydroxypropoxy]-benzonitrile,
4-[3-[ethyl[3-((R*)-(propylsulfinyl)propyl]amino]-2(S)-hydroxypropoxy]-benzonitrile,
4-[3-[ethyl[3-[((S*)-(propylsulfinyl)propyl]amino]-2(S)-hydroxypropoxy]-benzonitrile and
pharmaceutically acceptable salt thereof, processes for their preparation, as well as the use of said compounds for the preparation of medicaments with action against cardiac arrhythmias.
4-[3-[乙基[3-((R*)-(丙基亚磺酰)丙基]
氨基]-2(R)-羟基丙氧基]-苯腈、
4-[3-[乙基[3-((S*)-(丙基亚磺酰)丙基]
氨基]-2(R)-羟基丙氧基]-苯腈、
4-[3-[乙基[3-((R*)-(丙基亚磺酰)丙基]
氨基]-2(S)-羟基丙氧基]-苯腈、
4-[3-[乙基[3-[((S*)-(丙基亚磺酰)丙基]
氨基]-2(S)-羟基丙氧基]-苯腈及其
其药学上可接受的盐、其制备工艺,以及使用上述化合物制备具有抗心律失常作用的药物。